OGEN on NYSE

ORAGENICS INC

American pharmaceutical preparations company based in Tampa, active since 1996. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with BIO-PATH HOLDINGS, INC., Lyell Immunopharma, Inc. or AXIM BIOTECHNOLOGIES, INC., or pick any stock.

  • TickerOGEN on NYSE2
  • IndustryPharmaceutical Preparations2
  • HeadquartersTampa, United States2
  • Incorporated inFL3
  • Business address9015 Town Center Parkway, Suite 143, Lakewood Ranch, Fl 342023
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI549300639MGD19K4ZW902
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Catchur, Mark, Esq., 33602 Tampa, United States2
  • Registered withFlorida Division of Corporations, P960000919492

See how the biggest companies compare on our leaderboards

Uses Thereof have been filed in the U.S. with the USPTO as utility patent applications.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-55519.9%Operating margin5
-54858.1%Net margin5
-71.4%Revenue growth, 20235
-652.0%Return on equity6

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Research and development100¢$15.5M
  • Interest0¢$30.6K

Out of $37.7K in revenue.5 The company lost money this year.

Financial statements

Revenue785$37.7K in 2023−57% since 2021
0$50.0K$100.0K$150.0K2021: $87.0K$87.0K20212022: $131.5K$131.5K2022+51%2023: $37.7K$37.7K2023−71%
Operating income910785-$20.9M in 2023+32% since 2019
-$30.0M-$20.0M-$10.0M02019: -$15.9M-$15.9M20192020: -$26.6M-$26.6M2020+68%2021: -$15.8M-$15.8M2021−41%2022: -$14.4M-$14.4M2022−9%2023: -$20.9M-$20.9M2023+45%
Net income910785-$20.7M in 2023+33% since 2019
-$30.0M-$20.0M-$10.0M02019: -$15.6M-$15.6M20192020: -$26.4M-$26.4M2020+70%2021: -$15.7M-$15.7M2021−41%2022: -$14.3M-$14.3M2022−9%2023: -$20.7M-$20.7M2023+45%

Every line of the income statement as filed: the last 2 fiscal years, latest first.6

Period ending2025-12-312024-12-31
Research and development$2.4M$4.1M
General and administrative$7.0M$6.4M
Total operating expenses$9.4M$10.6M
Loss from operations-$9.4M-$10.6M
Interest income$182.2K$45.9K
Interest expense-$785.9K-$29.8K
Foreign currency exchange, net-$13.2K-$25.2K
Total other income (expense), net-$616.9K-$9.1K
Loss before income taxes-$10.0M-$10.6M
Income tax benefit$136.9K
Net loss-$9.8M-$10.6M
Basic net loss per share-$4.56-$47.88
Diluted net loss per share-$4.56-$47.88
Weight average shares outstanding, basic2.2M shares220.7K shares
Weight average shares outstanding, diluted2.2M shares220.7K shares

Compare ORAGENICS INC with another company

Leadership

Who has led ORAGENICS INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Robert T. Zahradnik2006
  2. Ronald P. Evens2008
  3. Stanley Bruce Stein2008
  4. John N. Bonfiglio2011–2014
  5. Alan Joslyn2016–2021
  6. Kimberly M. Murphy2022–2023
  7. Janet Huffman2025–now

President

  1. Robert T. Zahradnik2006
  2. Ronald P. Evens2008
  3. Stanley Bruce Stein2008
  4. John N. Bonfiglio2011–2014
  5. Alan Joslyn2016–2021
  6. Kimberly M. Murphy2022–2023
  7. J. Michael Redmond2024

Chief financial officer

  1. Dorothy Jean Delfino2007–2008
  2. Brian John Bohunicky2009–2011
  3. Michael O'Keefe Sullivan2012–2022
  4. Janet Huffman2023–now

Chief operating officer

  1. Robert T. Zahradnik2009
2010201520202025
Board members and other officers (23)

Timeline

  1. Dec 15, 2025New chief executive Janet Huffman becomes CEO13
  2. Jun 24, 2022New chief executive Kimberly M. Murphy becomes CEO14
  3. Jun 8, 2016New chief executive Alan Joslyn becomes CEO15
  4. May 26, 2011New chief executive John N. Bonfiglio becomes CEO16
  5. Apr 14, 2008New chief executive Stanley Bruce Stein becomes CEO18
  6. Jan 29, 2008New chief executive Ronald P. Evens becomes CEO17
  7. Sep 11, 2006New chief executive Robert T. Zahradnik becomes CEO19
  8. Nov 6, 1996Founded ORAGENICS INC is founded2

Filings

284 filings to the SEC since October 2021: 6 annual reports, 18 quarterly reports, 106 major events, 70 insider forms, 6 large holders, 1 private raises, 77 other. The latest 20:

  1. Sep 16, 20268-K EDGAR
  2. Aug 28, 20268-K EDGAR
  3. Aug 13, 202610-Q EDGAR
  4. Jul 7, 20264 PRIMARY DOCUMENT EDGAR
  5. Jul 7, 20263 PRIMARY DOCUMENT EDGAR
  6. Jul 6, 20268-K EDGAR
  7. May 20, 2026DEFA14A EDGAR
  8. May 20, 2026DEF 14A EDGAR
  9. May 19, 20268-K EDGAR
  10. May 8, 2026PRE 14A EDGAR
  11. May 8, 202610-Q EDGAR
  12. May 7, 20268-K EDGAR
  13. Apr 13, 20268-K EDGAR
  14. Mar 31, 20268-K EDGAR
  15. Mar 20, 2026EFFECT EDGAR
  16. Mar 19, 2026CORRESP EDGAR
  17. Mar 19, 2026S-3/A EDGAR
  18. Mar 16, 202610-K EDGAR
  19. Mar 11, 20268-K EDGAR
  20. Jan 27, 2026UPLOAD EDGAR

The 284 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

29 open-market trades by officers, directors and large owners since October 2021: 11 buys and 18 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 12, 2025Telling FredDirectorSale210$0.94$197Form 4
Dec 12, 2025Telling FredDirectorSale210$0.94$197Form 4
Jun 18, 2025Odyssey Health, Inc.10% ownerSale5,044$4.26$21.5KForm 4
Jun 17, 2025Odyssey Health, Inc.10% ownerSale2,000$4.46$8.9KForm 4
Jun 16, 2025Odyssey Health, Inc.10% ownerSale5,000$4.45$22.2KForm 4
Jun 13, 2025Odyssey Health, Inc.10% ownerSale5,000$4.27$21.4KForm 4
Dec 6, 2024DUNTON ALAN WDirectorSale66$0.36$24Form 4
Dec 6, 2024Telling FredDirectorSale3,597$0.36$1.3KForm 4
Nov 30, 2023Telling FredDirectorSale3,500$3.57$12.5KForm 4
Dec 30, 2022KOSKI ROBERT CDirectorSale42,357$0.11$4.7KForm 4
Dec 29, 2022KOSKI ROBERT CDirectorSale36,648$0.11$4.0KForm 4
Dec 15, 2022KOSKI ROBERT CDirectorSale140,497$0.18$25.3KForm 4
Dec 14, 2022KOSKI ROBERT CDirectorSale25,000$0.18$4.5KForm 4
Dec 14, 2022KOSKI ROBERT CDirectorSale4,503$0.18$811Form 4
Dec 9, 2022KOSKI ROBERT CDirectorSale48,795$0.20$9.8KForm 4
Dec 8, 2022KOSKI ROBERT CDirectorSale13,036$0.20$2.6KForm 4
Nov 30, 2022KOSKI ROBERT CDirectorSale200,000$0.19$38.0KForm 4
Nov 29, 2022KOSKI ROBERT CDirectorSale200,000$0.19$38.0KForm 4
Jun 17, 2022Telling FredDirectorBuy10,084$0.29$2.9KForm 4
May 24, 2022Telling FredDirectorBuy78,673$0.29$22.8KForm 4

All 29 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Aug 4, 2023Raised $850,000 in a private offering of equity Form D: 2 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Geode Capital Management, LLC23,685$13.8K0.0%−41,387
25 LLC23,160$13.4K0.0%New
Jane Street Group, LLC12,771$7.4K0.0%New
Tower Research Capital LLC (TRC)4,548$2.6K0.0%No change
St. Johns Investment Management Company, LLC1,924$1.1K0.0%+1,724
BlackRock, Inc.703$4080.0%No change
UBS Group AG642$3730.0%−4,563
Wells Fargo & Company/mn34$200.0%No change
Harbour Investments, Inc.34$200.0%No change
SBI Securities Co., Ltd.23$130.0%+12
Adkins Seale Capital Management LLC3$20.0%No change
Johnson Financial Group, Inc.1$10.0%No change
Bogart Wealth, LLC1$10.0%No change
Strategic Wealth Partners, Ltd.1$10.0%No change
Farther Finance Advisors, LLC1$10.0%No change
Keating Financial Advisory Services, Inc.1$10.0%No change
Fmr LLC0$00.0%No change
Royal Bank Of Canada2$00.0%+1

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47